http://www.myfoxdc.com/dpp/health/australian-drug-maker-close-to-a-cure-for-the-common-cold-ncxdc-032812#ixzz1qSoxOVxN
MELBOURNE, Australia - Taking sick days is set to get tougher -- there may be a cure for the common cold.
Australian drug maker Biota Wednesday reported the stunning success of its antiviral compound, named Vapendavir.
Tested in 300 asthmatic patients infected with the cold-causing human rhinovirus, the clinical trial showed that cold symptoms eased quickly and the duration of the infection was shortened considerably.
Read more: http://www.myfoxdc.com/dpp/health/australian-drug-maker-close-to-a-cure-for-the-common-cold-ncxdc-032812#ixzz1qYQi9JNF
